V. Golder, MBBS, PhD, R. Kandane-Rathnayake, PhD, A. Hoi, MBBS, PhD, E.F. Morand, MBBS, PhD, Monash University, Melbourne, Australia;
V. Golder, MBBS, PhD, R. Kandane-Rathnayake, PhD, A. Hoi, MBBS, PhD, E.F. Morand, MBBS, PhD, Monash University, Melbourne, Australia.
J Rheumatol. 2024 Aug 1;51(8):790-797. doi: 10.3899/jrheum.2023-0900.
To assess whether Lupus Low Disease Activity State (LLDAS) attainment is associated with favorable outcomes in patients with recent onset systemic lupus erythematosus (SLE).
Data from a 13-country longitudinal SLE cohort were collected prospectively between 2013 and 2020. An inception cohort was defined based on disease duration < 1 year at enrollment. Patient characteristics between inception and noninception cohorts were compared. Survival analyses were performed to examine the association between LLDAS attainment and damage accrual and flare.
Of the total 4106 patients, 680 (16.6%) were recruited within 1 year of SLE diagnosis (inception cohort). Compared to the noninception cohort, inception cohort patients were significantly younger, had higher disease activity, and used more glucocorticoids, but had less organ damage at enrollment. Significantly fewer inception cohort patients were in LLDAS at enrollment than the noninception cohort (29.6% vs 52.3%, < 0.001), but three-quarters of both groups achieved LLDAS at least once during follow-up. Limiting analysis only to patients not in LLDAS at enrollment, inception cohort patients were 60% more likely to attain LLDAS (hazard ratio 1.37, 95% CI 1.16-1.61, < 0.001) than noninception cohort patients and attained LLDAS significantly faster. LLDAS attainment was significantly protective against flare in both the inception and noninception cohorts. A total of 88 (13.6%) inception cohort patients accrued organ damage during a median 2.2 years of follow-up.
LLDAS attainment is protective from flare in recent onset SLE. Significant protection from damage accrual was not observed because of low rates of damage accrual in the first years after SLE diagnosis. (ClinicalTrials.gov: NCT03138941).
评估狼疮低疾病活动状态(LLDAS)的达标是否与近期发病的系统性红斑狼疮(SLE)患者的良好结局相关。
这项在 13 个国家进行的纵向 SLE 队列研究的数据是在 2013 年至 2020 年期间前瞻性收集的。根据入组时疾病持续时间<1 年定义了一个发病队列。比较了发病和非发病队列患者的特征。进行生存分析以检查 LLDAS 达标与损伤累积和发作的关系。
在总共 4106 名患者中,680 名(16.6%)在 SLE 诊断后 1 年内被招募(发病队列)。与非发病队列相比,发病队列患者年龄明显较小,疾病活动度更高,且使用更多的糖皮质激素,但在入组时器官损伤较少。与非发病队列相比,发病队列患者在入组时处于 LLDAS 的比例明显较低(29.6%比 52.3%,<0.001),但两组患者在随访期间均有四分之三达到了 LLDAS。仅对入组时未达到 LLDAS 的患者进行限制分析,发病队列患者达到 LLDAS 的可能性比非发病队列患者高 60%(风险比 1.37,95%CI 1.16-1.61,<0.001),且达到 LLDAS 的速度明显更快。在发病和非发病队列中,达到 LLDAS 均能显著降低发作的风险。在中位 2.2 年的随访期间,共有 88 名(13.6%)发病队列患者发生器官损伤。
在近期发病的 SLE 中,达到 LLDAS 可防止发作。由于 SLE 诊断后最初几年损伤累积率较低,因此未观察到对损伤累积的显著保护作用。(ClinicalTrials.gov:NCT03138941)。